Pokemon silencing leads to bim-mediated anoikis of human hepatoma cell QGY7703

International Journal of Molecular Sciences

Volumn 13, Issue 5, 2012, Pages 5818-5831

  Liu, Kun ^a   Liu, Feng ^a   Zhang, Nannan ^a   Liu, Shiying ^a   Jiang, Yuyang ^a,b  

^a TSINGHUA UNIVERSITY   (China)

^b Tsinghua University   (China)

Author keywords

Anoikis; Bim; Hepatoma; Pokemon

Indexed keywords

BIM PROTEIN; CASPASE 3; DOXORUBICIN; ONCOPROTEIN; POKEMON PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BCL-2-LIKE PROTEIN 11; DNA BINDING PROTEIN; MEMBRANE PROTEIN; TRANSCRIPTION FACTOR; ZBTB7A PROTEIN, HUMAN;

ANOIKIS; APOPTOSIS; ARTICLE; CANCER INVASION; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GENETIC TRANSCRIPTION; HEPATOMA CELL; HUMAN; HUMAN CELL; METASTASIS; POKEMON GENE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTO ONCOGENE; UPREGULATION; GENETICS; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ANOIKIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; LIVER NEOPLASMS; MEMBRANE PROTEINS; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84861716941     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13055818     Document Type: Article

References (32)

1. Morrison, D.J.; Pendergrast, P.S.; Stavropoulos, P.; Colmenares, S.U.; Kobayashi, R.; Hernandez, N. FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein. Nucleic Acids Res. 1999, 27, 1251-1252.
2. Maeda, T.; Merghoub, T.; Hobbs, R.M.; Dong, L.; Maeda, M.; Zakrzewski, J.; van den Brink, M.R.M.; Zelent, A.; Shigematsu, H.; Akashi, K.; et al. Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF. Science 2007, 316, 860-866.
3. Maeda, T.; Ito, K.; Merghoub, T.; Poliseno, L.; Hobbs, R.M.; Wang, G.; Dong, L.; Maeda, M.; Dore, L.C.; Zelent, A.; et al. LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis. Dev. Cell 2009, 17, 527-540.
4. Ji, Y.; He, X.S.; Ma, Y.; Zhu, X.F.; Zhang, R.; Wu, J. Expression of Pokemon in HCC, HCC with distant place metastasis, hepatocirrhosis and normal crowds. Chin. J. Exp. Surg. 2007, 24, 75-79.
5. Rovin, R.A.; Winn, R. Pokemon expression in malignant glioma: An application of bioinformatics methods. Neurosurg. Focus 2005, 19, 1-2.
6. Aggarwal, A.; Hunter, W.J.; Aggarwal, H.; Silva, E.D.; Davey, M.S.; Murphy, R.F.; Agrawal, D.K. Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers. Exp. Mol. Pathol. 2010, 89, 140-148.
7. Maeda, T.; Hobbs, R.M.; Merghoub, T.; Guernah, I.; Arthur, Z.; Cordon-Cardo, C.; Teruya-Feldstein, J.; Pandolfi, P.P. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 2005, 433, 278-285.
8. Maeda, T.; Hobbs, R.M.; Pandolfi, P.P. The transcription factor Pokemon: A new key player in cancer pathogenesis. Cancer Res. 2005, 65, 8575.
9. El-Deiry, W.S.; Tokinom, T.; Velculescu, V.E.; Levy, D.B.; Parsons, R.; Trent, J.M.; Lin, D.; Mercer, W.E.; Kinzler, K.W.; Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75, 817-825.
10. El-Deiry, W.S.; Harper, J.W.; O'Connor, P.M.; Velculescu, V.E.; Canman, C.E.; Jackman, J.; Pietenpol, J.A.; Burrell, M.; Hill, D.E.; Wang Y.; et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 1994, 54, 1169-1174.
11. Ezhevsky, S.A.; Ho, A.; Becker-Hapak, M.; Davis, P.K.; Dowdy, S.F. Differential regulation of retinoblastoma tumor suppressor protein by G1 cyclin-dependent kinase complexes in vivo. Mol. Cell. Biol. 2001, 21, 4773-4784.
12. Goodrich, D.W.; Wang, N.P.; Qian, Y.W.; Lee, E.Y.; Lee, W.H. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 1981, 67, 293-302.
13. Choi, W.I.; Jeon, B.N.; Yun, C.O.; Kim, P.H.; Kim, S.E.; Choi, K.Y.; Kim, S.H.; Hur, M.W. Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1. J. Biol. Chem. 2009, 284, 12633-12644.
14. Jeon, B.N.; Yoo, J.Y.; Choi, W.I.; Lee, C.E.; Yoon, H.G.; Hur, M.W. Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb Gene via binding competition with Sp1 and recruitment of co-repressors. J. Biol. Chem. 2008, 283, 33199-33210.
15. Choi, W.I.; Jeon, B.N.; Park, H.; Yoo, J.Y.; Kim, Y.S.; Koh, D.I.; Kim, M.H.; Kim, Y.R.; Lee, C.E.; Kim, K.S.; et al. Proto-oncogene FBI-1 (Pokemon) and SREBP-1 synergistically activate transcription of fatty-acid synthase gene (FASN). J. Biol. Chem. 2008, 283, 29341-29354.
16. Kuhajda, F.P. Fatty acid synthase and cancer: New application of an old pathway. Cancer Res. 2006, 66, 5977-5980.
17. Bouillet, P.; Zhang, L.C.; Huang, D.C.S.; Webb, G.C.; Bottema, C.D.K.; Shore, P.; Eyre, H.J.; Sutherland, G.R.; Adams, J.M. Gene structure, alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim. Mamm. Genome 2001, 12, 163-168.
18. Adams, J.M.; Cory, S. The Bcl-2 protein family: Arbiters of cell survival. Science 1998, 281, 1322-1326.
19. Gilmore, A.P.; Metcalfe, A.D.; Romer, L.H.; Streuli, C.H. Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization. J. Cell. Biochem. 2000, 149, 431-446.
20. Lindsten, T.; Ross, A.J.; King, A.; Zong, W.X.; Rathmell, J.C.; Shiels, H.A.; Ulrich, E.; Waymire, K.G.; Mahar, P.; Frauwirth, K. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 2000, 6, 1389-1399.
21. Schwartz, M.A. Integrins, oncogenes, and anchorage independence. J. Cell. Biochem. 1997, 139, 575-578.
22. Chiarugi, P.; Giannoni, E. Anoikis: A necessary death program for anchorage-dependent cells. Biochem. Pharmacol. 2008, 76, 1352-1364.
23. Frisch, S.M.; Ruoslahti, E. Integrins and anoikis. Curr. Opin. Cell Biol. 1997, 9, 701-706.
24. Li, Z.; Zhao, J.; Du, Y.; Park, H.R.; Sun, S.Y.; Bernal-Mizrachi, L.; Aitken, A.; Khuri, F.R.; Fu, H. Down-regulation of 14-3-3ζ suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc. Natl. Acad. Sci. USA 2008, 105, 162-167.
25. Gan, L.; Liu, P.; Lu, H.; Chen, S.; Yang, J.; McCarthy, J.; Knudsen, K.; Huang, H. Cyclin D1 promotes anchorage-independent cell survival by inhibiting FOXO-mediated anoikis. Cell Death Differ. 2009, 16, 1408-1417.
26. Woods, N.T.; Yamaguchi, H.; Lee, F.Y.; Bhalla, K.N.; Wang, H.G. Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis. Cancer Res. 2007, 67, 10744-10752.
27. Frisch, S.M.; Screaton, R.A. Anoikis mechanisms. Curr. Opin. Cell Biol. 2001, 13, 555-562.
28. Hanahan, D. The hallmarks of cancer. Cell 2000, 100, 57-70.
29. Zu, X.; Ma, J.; Liu, H.; Liu, F.; Tan, C.; Yu, L.; Wang, J.; Xie, Z.; Cao, D.; Jiang, Y. Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression. Breast Cancer Res. 2011, 13, doi:10.1186/bcr2843.
30. Parkin, D.M.; Pisani, P.; Ferlay, J. Global cancer statistics. CA Cancer J. Clin. 1999, 49, 33-64.
31. Ku, S.C.Y.; Ng, D.T.W.; Yap, M.G.S.; Chao, S.H. Effects of overexpression of X-box binding protein 1 on recombinant protein production in Chinese hamster ovary and NS0 myeloma cells. Biotechnol. Bioeng. 2008, 99, 155-164.
32. He, S.; Liu, F.; Xie, Z.; Zu, X.; Xu, W.; Jiang, Y. P-Glycoprotein/MDR1 regulates Pokemon gene transcription through p53 expression in human breast cancer cells. Int. J. Mol. Sci. 2010, 11, 3039-3051.